Global Bioreactors Market Size & Trends Report Segmented by Type (Single-Use, Stirred-Tank, Airlift), Material (Glass, Stainless Steel, Single-Use), Usage (Lab-Scale, Pilot-Scale, Large-Scale), End-user (Biopharmaceutical Companies, CMOs) & Regional Forecast to 2030
The global bioreactors market is expected to grow at a CAGR of ~7%, driven by increasing demand for biopharmaceuticals like monoclonal antibodies, gene therapies, and advanced vaccines. The adoption of single-use bioreactors (SUBs) is accelerating due to their advantages in reducing downtime & contamination risks and enhancing manufacturing flexibility. CDMOs are heavily investing in SUBs to support biologics production, particularly in personalized medicine and rare disease treatments. However, high capital costs, stringent regulatory approvals, and scalability challenges remain key hurdles for large-scale bioprocessing. To learn more about the research report, download a sample report.
Report Overview
Bioreactors are controlled environments designed for biological reactions that enable the growth of cells, microorganisms, or tissues for applications in pharmaceuticals, biotechnology, and bioengineering. These systems play a crucial role in producing monoclonal antibodies, vaccines, and cell-based therapies, where precision, sterility, and scalability are essential. Traditional bioreactors, such as stirred tanks or airlift designs, have long been industry standards, but advancements in automation and single-use technologies are reshaping the landscape. The latest bioreactors integrate real-time monitoring, adaptive control mechanisms, and AI-driven process optimization to enhance biomanufacturing efficiency while maintaining stringent regulatory compliance.
To learn more about this report, download the PDF brochure
Expanding role of biopharmaceuticals in market growth
The growing demand for biopharmaceuticals is the most significant force shaping the bioreactors market. Unlike traditional small-molecule drugs, biologics such as monoclonal antibodies, recombinant proteins, and cell-based therapies require highly controlled environments for production, making bioreactors indispensable. The increasing prevalence of chronic diseases, including cancer, autoimmune disorders, and rare genetic conditions, has driven pharmaceutical companies to expand bioprocessing capabilities, ensuring high-yield, high-purity biologics.
In addition to established therapies, cell and gene therapies (CGT) have emerged as novel therapies, with CAR-T cell treatments and regenerative medicine demanding highly specialized bioreactor systems. To meet this demand, companies are shifting from traditional stainless-steel bioreactors to single-use models, allowing faster turnaround between batches and reducing cleaning validation requirements. Additionally, partnerships between biopharma firms and CDMOs have surged, enabling more efficient and cost-effective biologics production. With regulators approving an increasing number of biologic therapies, the need for advanced bioreactor systems will continue accelerating.
Advances in single-use bioreactors enhancing market potential
One of the most transformative shifts in the bioreactors market is the widespread adoption of SUBs. Unlike traditional stainless-steel systems that require extensive sterilization and cleaning, SUBs use pre-sterilized disposable bags, eliminating cross-contamination risks and significantly reducing downtime between production cycles. This has made them particularly valuable for small-batch biologics, personalized therapies, and pandemic-driven rapid vaccine production.
A key advancement is the integration of continuous bioprocessing with single-use technologies, enabling uninterrupted manufacturing and higher throughput efficiency. Additionally, AI-powered bioprocess monitoring systems are revolutionizing SUB operations by providing real-time adjustments to parameters like pH, oxygen concentration, and glucose levels, ensuring optimal cell growth conditions. Another innovation is the emergence of modular and scalable SUB platforms, which allow manufacturers to expand production capacity without the constraints of fixed infrastructure.
Furthermore, regulatory bodies such as the FDA and EMA have increasingly endorsed single-use technologies, recognizing their role in reducing contamination risks and accelerating drug production timelines. As pharmaceutical companies continue seeking flexible and cost-efficient biomanufacturing solutions, SUBs will dominate the next phase of biologics production, driving innovation in reactor design, process control, and automation.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global bioreactors market is marked by the presence of established and emerging market players such as Thermo Fisher Scientific; Sartorius AG; GE Healthcare; Merck KGaA; Danaher Corporation; Eppendorf AG; Lonza Group AG; Solaris Biotechnology Srl.; Bioengineering AG; and Infors HT, among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 – 2030 |
| Growth Rate | ~7% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Type, Material, Usage, and End-user |
| Regional Scope |
|
| Key Companies Mapped | Thermo Fisher Scientific; Sartorius AG; GE Healthcare; Merck KGaA; Danaher Corporation; Eppendorf AG; Lonza Group AG; Solaris Biotechnology Srl.; Bioengineering AG; and Infors HT, among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Bioreactors Market Segmentation
This report by Medi-Tech Insights provides the size of the global bioreactors market at the regional- and country-level from 2023 to 2030. The report further segments the market based on type, material, usage and end-user.
Market Size & Forecast (2023-2030), By Type, USD Million
- Single-Use Bioreactors
- Stirred-Tank Bioreactors
- Airlift Bioreactors
- Others
Market Size & Forecast (2023-2030), By Material, USD Million
- Glass
- Stainless Steel
- Single-Use
Market Size & Forecast (2023-2030), By Usage, USD Million
- Lab-Scale
- Pilot-Scale
- Large-Scale
Market Size & Forecast (2023-2030), By End-user, USD Million
- Biopharmaceutical Companies
- Academic & Research Institutes
- Contract Manufacturing Organizations (CMOs)
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the bioreactors market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the bioreactors market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Bioreactors Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Increasing demand for biopharmaceuticals
- Growing adoption of single-use bioreactors
- Expansion of cell and gene therapy applications requiring advanced bioprocessing
- Rising investments in biomanufacturing infrastructure and contract manufacturing
- Technological advancements in automation and real-time bioprocess monitoring
- Restraints
- High capital investment and operational costs for large-scale biomanufacturing
- Stringent regulatory requirements for bioprocess validation and compliance
- Challenges in scaling up bioreactors while maintaining consistent product quality
- Opportunities
- Shift toward continuous bioprocessing for higher efficiency and productivity
- Expanding role of bioreactors in regenerative medicine and stem cell therapies
- Increasing biopharma outsourcing to CDMOs
- Adoption of 3D-printed bioreactors for precision cell culture applications
- Key Market Trends
- Development of modular and scalable bioreactor designs for flexible manufacturing
- Integration of artificial intelligence (AI) and machine learning in bioreactor control systems
- Unmet Market Needs
- Industry Speaks
- Drivers
- Market Dynamics
- Global Bioreactors Market Size & Forecast (2023-2030), By Type, USD Million
- Introduction
- Single-Use Bioreactors
- Stirred-Tank Bioreactors
- Airlift Bioreactors
- Others
- Global Bioreactors Market Size & Forecast (2023-2030), By Material, USD Million
- Introduction
- Glass
- Stainless Steel
- Single-Use
- Global Bioreactors Market Size & Forecast (2023-2030), By Usage, USD Million
- Introduction
- Lab-Scale
- Pilot-Scale
- Large-Scale
- Global Bioreactors Market Size & Forecast (2023-2030), By End-user, USD Million
- Introduction
- Biopharmaceutical Companies
- Academic & Research Institutes
- Contract Manufacturing Organizations (CMOs)
- Others
- Global Bioreactors Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Bioreactors Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By Usage (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Canada
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By Usage (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- US
- Europe Bioreactors Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By Usage (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Germany
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By Usage (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- France
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By Usage (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Italy
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By Usage (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Spain
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By Usage (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Europe
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By Usage (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- UK
- Asia Pacific (APAC) Bioreactors Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By Usage (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Japan
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By Usage (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- India
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By Usage (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By Usage (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- China
- Latin America (LATAM) Bioreactors Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By Usage (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Middle East & Africa (MEA) Bioreactors Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By Usage (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Thermo Fisher Scientific
- Sartorius AG
- GE Healthcare
- Merck KGaA
- Danaher Corporation
- Eppendorf AG
- Lonza Group AG
- Solaris Biotechnology Srl.
- Bioengineering AG
- Infors HT
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Biopharmaceutical Companies, Academic & Research Institutes, Contract Manufacturing Organizations (CMOs) and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
